Lilia Escobar
Physician Assistant · Rio Grande City, TXNPI 1134545387
Payments from drug & device makers
Across 356 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Lilly USA, LLC$617
- Novo Nordisk$586
- Merck$576
- Sumitomo Pharma America, Inc.$332
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,97799%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,465 |
| AstraZeneca(2 entities) | 55 | $1,116 |
| Lilly USA, LLC | 42 | $617 |
| Novo Nordisk | 48 | $586 |
| Merck | 31 | $576 |
| Sumitomo Pharma America, Inc. | 12 | $332 |
| Amgen | 17 | $249 |
| Johnson & Johnson | 7 | $146 |
| Boehringer Ingelheim | 6 | $120 |
| Astellas Pharma US Inc | 7 | $108 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $105 |
| Pfizer | 4 | $72 |
| Bayer | 3 | $63 |
| Abbott | 3 | $63 |
| Exact Sciences | 3 | $60 |
| Novartis | 3 | $60 |
| Philips North America LLC | 3 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,016 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 389 | $419,784 |
| OzempicSemaglutide | 411 | $409,361 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 259 | $224,528 |
| LinzessLinaclotide | 158 | $144,255 |
| JardianceEmpagliflozin | 89 | $102,482 |
| FarxigaDapagliflozin Propanediol | 65 | $78,654 |
| JanuviaSitagliptin Phosphate | 72 | $75,286 |
| ProliaDenosumab | 42 | $70,430 |
| RybelsusSemaglutide | 44 | $64,014 |
| MyrbetriqMirabegron | 62 | $63,007 |
| TrulicityDulaglutide | 43 | $51,650 |
| EntrestoSacubitril/Valsartan | 40 | $42,399 |
| EliquisApixaban | 39 | $39,137 |
| XareltoRivaroxaban | 28 | $39,016 |
| TradjentaLinagliptin | 39 | $35,515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $586 | $473,375455 claims |
| Lilly USA, LLCMounjaro, Trulicity | $617 | $471,434432 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $1,116 | $303,182324 claims |
| Boehringer IngelheimJardiance, Tradjenta, Trijardy Xr, Glyxambi, Synjardy Xr | $120 | $224,081192 claims |
| AbbVieLinzess, Vraylar, Namzaric | $1,465 | $199,086199 claims |
| MerckJanuvia, Janumet Xr | $576 | $103,66899 claims |
| AmgenProlia | $249 | $70,43042 claims |
| Astellas Pharma US IncMyrbetriq | $108 | $63,00762 claims |
| NovartisEntresto | $60 | $42,39940 claims |
| PfizerEliquis | $72 | $39,13739 claims |
| Johnson & JohnsonXarelto | $146 | $39,01628 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $332 | $14,81219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Rio Grande City
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.